Valuation: EQL Pharma AB

Market Cap 601M 63.01M 54.77M 50.98M 46.81M 88.39M 6.01B 89.76M 236M 2.99B 237M 231M 10.04B P/E 2027 *
42.4x
P/E 2028 * 9.55x
Enterprise Value 983M 103M 89.59M 83.39M 76.56M 145M 9.84B 147M 386M 4.9B 387M 379M 16.42B EV / Sales 2027 *
2.05x
EV / Sales 2028 * 1.6x
Free-Float
38.91%
Yield 2027 *
-
Yield 2028 * -
1 day-1.45%
1 week-1.21%
1 month-12.10%
3 months-59.14%
6 months-68.35%
Current year-64.79%
1 week 19.2
Extreme 19.2
21.15
1 month 19.2
Extreme 19.2
24.3
Current year 19.2
Extreme 19.2
67.5
1 year 19.2
Extreme 19.2
96.8
3 years 19.2
Extreme 19.2
98.6
5 years 19.2
Extreme 19.2
98.6
10 years 6.35
Extreme 6.35
98.6
Manager TitleAgeSince
Chief Executive Officer 40 2022-08-16
Director of Finance/CFO 51 2026-03-31
Chief Operating Officer 48 2022-08-16
Director TitleAgeSince
Chairman 61 2022-08-16
Chairman 59 -
Director/Board Member 53 2019-12-31
Date Insider Type Main position Quantity % Market Cap.
12/30/25 Buy

Executive/Senior Manager

1,000 0.0034%
12/23/25 Buy

Chief Operating Officer

19,225 0.0651%
9/26/25 Buy

Executive/Senior Manager

1,000 0.0034%
Change 5-day change 1-year change 3-year change Capi.($)
-1.45%-1.21%-77.86%-26.80% 63.01M
-0.66%+3.92%-21.35%-26.34% 16.03B
+0.14%+5.57%-26.68%-33.09% 7.4B
-1.05%+0.04%-21.57%-5.74% 6.26B
+0.13%+4.36%-6.11%-29.94% 4.08B
+1.00%+3.23%-22.46%-43.73% 3.32B
-1.46%+2.45%+8.21%-34.41% 3.18B
+1.37%+3.90%-41.35%-21.77% 3.12B
-0.51%+2.07%-10.53%+7.46% 2.7B
-4.05%-2.27%+94.44% - 2.5B
Average -0.62%+2.42%-12.53%-23.82% 4.86B
Weighted average by Cap. -0.38%+4.30%-13.85%-24.47%

Financials

2027 *2028 *
Net sales 480M 50.33M 43.75M 40.72M 37.39M 70.6M 4.8B 71.7M 188M 2.39B 189M 185M 8.02B 634M 66.47M 57.79M 53.79M 49.38M 93.25M 6.35B 94.7M 249M 3.16B 250M 244M 10.59B
Net income 14M 1.47M 1.28M 1.19M 1.09M 2.06M 140M 2.09M 5.49M 69.76M 5.51M 5.39M 234M 63M 6.61M 5.74M 5.34M 4.91M 9.27M 631M 9.41M 24.73M 314M 24.81M 24.26M 1.05B
Net Debt 382M 40.05M 34.82M 32.41M 29.75M 56.19M 3.82B 57.06M 150M 1.9B 150M 147M 6.38B 412M 43.2M 37.55M 34.95M 32.09M 60.6M 4.12B 61.54M 162M 2.05B 162M 159M 6.88B
Logo EQL Pharma AB
EQL Pharma AB is a Sweden-based Company that operates as a generic drugs and specialty pharmaceutical company. The Company engages in marketing, distributing, and selling generic drugs and specialty pharmaceuticals. Its main products are Anastrozol, Venlafaxin, Carvedilol, Metformin, Sumatriptan, Mometason, Glepark, among others. The company operates in Sweden and in Scandinavia.
Employees
23
Date Price Change Volume
26-07-31 SEK 20.35 -1.45% 21,197
26-07-30 SEK 20.65 +2.74% 57,712
26-07-29 SEK 20.10 -2.66% 58,168
26-07-28 SEK 20.65 -0.96% 31,740
26-07-27 SEK 20.85 +1.21% 25,739
Trader
Investor
Global
-
Quality
ESG MSCI
-

Quarterly revenue - Rate of surprise